• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耳霉菌病的临床表现、聚类分析及实验室研究——单中心经验

Clinical Presentations, Cluster Analysis and Laboratory-Based Investigation of Otomycosis-A Single Center Experience.

作者信息

Bojanović Mila, Ignjatović Aleksandra, Stalević Marko, Arsić-Arsenijević Valentina, Ranđelović Marina, Gerginić Vladimir, Stojanović-Radić Zorica, Stojković Ognjen, Živković-Marinkov Emilija, Otašević Suzana

机构信息

Medical Faculty, University of Niš, 18000 Niš, Serbia.

Clinic of Otorhinolaryngology, University Clinical Center Niš, 18000 Niš, Serbia.

出版信息

J Fungi (Basel). 2022 Mar 18;8(3):315. doi: 10.3390/jof8030315.

DOI:10.3390/jof8030315
PMID:35330316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948793/
Abstract

Species of () complex and complex are predominant molds that are causative agents of otomycoses. The goal of this study was to investigate the clinical presentation, diagnostic procedure, and appearance of relapse in patients with -otomycosis, as well as to determine the biofilm production ability of species isolated in relapse. Thirty patients with laboratory evidenced -otomycosis followed by two check-ups (30 and 60 days after initiation of treatment with antimycotics for local application) were included in the study. For isolation and identification of spp. the standard mycological procedure was applied. Results showed very high sensitivity of microscopy, but 16.7% species required the optimal temperature of 27-28 °C for cultivation. Applied statistical cluster analysis showed a defined specific cluster/group of patients with complex-otomycosis. Sixty days after diagnosis and treatment initiation, six patients had a relapse, with the same species of genus being the cause. To establish the ability of biofilm production, the modified method described by Pierce and Kvasničková was performed, and all six species isolated in the relapse episode had the ability to produce biofilm. Official criteria and recommendations are needed due to the possibility of misdiagnosis, which leads to the prolongation and complication of the disease.

摘要

()复合体和复合体的物种是耳真菌病的主要致病霉菌。本研究的目的是调查耳真菌病患者的临床表现、诊断程序和复发情况,以及确定复发时分离出的物种的生物膜形成能力。30例经实验室证实患有耳真菌病并随后进行两次检查(局部应用抗真菌药物治疗开始后30天和60天)的患者被纳入研究。对于分离和鉴定 spp.,采用了标准的真菌学程序。结果显示显微镜检查的敏感性非常高,但16.7%的物种需要27 - 28°C的最佳温度进行培养。应用统计聚类分析显示了一组明确的患有复合体耳真菌病的特定患者群。诊断和治疗开始60天后,6例患者复发,病因是同一属的物种。为确定生物膜形成能力,采用了Pierce和Kvasničková描述的改良方法,复发期分离出的所有6个物种都有形成生物膜的能力。由于存在误诊的可能性,这会导致疾病的延长和并发症,因此需要官方标准和建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ee/8948793/eec1c383e723/jof-08-00315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ee/8948793/7da306d0cc38/jof-08-00315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ee/8948793/eec1c383e723/jof-08-00315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ee/8948793/7da306d0cc38/jof-08-00315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ee/8948793/eec1c383e723/jof-08-00315-g002.jpg

相似文献

1
Clinical Presentations, Cluster Analysis and Laboratory-Based Investigation of Otomycosis-A Single Center Experience.耳霉菌病的临床表现、聚类分析及实验室研究——单中心经验
J Fungi (Basel). 2022 Mar 18;8(3):315. doi: 10.3390/jof8030315.
2
Etiology, Predisposing Factors, Clinical Features and Diagnostic Procedure of Otomycosis: A Literature Review.耳真菌病的病因、诱发因素、临床特征及诊断方法:文献综述
J Fungi (Basel). 2023 Jun 13;9(6):662. doi: 10.3390/jof9060662.
3
[Agents of otomycosis in Manisa region, Turkey, 1995-2011].[1995 - 2011年土耳其马尼萨地区耳霉菌病病原体]
Mikrobiyol Bul. 2012 Jan;46(1):79-84.
4
Etiologic Agents of Otomycosis in the North-Western Area of Iran.伊朗西北部地区耳霉菌病的病原体
Jundishapur J Microbiol. 2015 Sep 8;8(9):e21776. doi: 10.5812/jjm.21776. eCollection 2015 Sep.
5
Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia.东南塞尔维亚地区的耳真菌病的物种分布模式和流行病学特征。
J Mycol Med. 2020 Sep;30(3):101011. doi: 10.1016/j.mycmed.2020.101011. Epub 2020 Jun 30.
6
Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.从耳真菌病患者中分离出的酵母和霉菌的分子鉴定及抗真菌药敏试验。
Mycopathologia. 2021 May;186(2):245-257. doi: 10.1007/s11046-021-00537-1. Epub 2021 Mar 15.
7
Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.从中国西部耳真菌病患者中分离出的曲霉菌的分子鉴定及体外抗真菌药敏试验。
Mycopathologia. 2020 Jun;185(3):527-535. doi: 10.1007/s11046-020-00448-7. Epub 2020 Apr 28.
8
Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.从耳真菌病患者中分离的曲霉属 Nigri 节段菌株的种属鉴定和体外抗真菌药敏试验。
J Mycol Med. 2018 Jun;28(2):279-284. doi: 10.1016/j.mycmed.2018.02.003. Epub 2018 Mar 11.
9
Black aspergilli as causes of otomycosis in the era of molecular diagnostics, a mini-review.黑曲霉作为分子诊断时代真菌性外耳道炎的病因:一篇小型综述。
J Mycol Med. 2022 May;32(2):101240. doi: 10.1016/j.mycmed.2021.101240. Epub 2021 Dec 28.
10
Prevalence of otomycosis in Ibadan: a review of laboratory reports.伊巴丹耳霉菌病的患病率:实验室报告综述
Afr J Med Med Sci. 2010 Dec;39 Suppl:219-22.

引用本文的文献

1
Superficial Candidiasis: Cluster Analysis of Species Distribution and Their Antifungal Susceptibility In Vitro.浅部念珠菌病:菌种分布及其体外抗真菌药敏性的聚类分析
J Fungi (Basel). 2025 Apr 25;11(5):338. doi: 10.3390/jof11050338.
2
[Analysis of fungal infections of external auditory canal and its risk factors in patients with chronic otitis media].[慢性中耳炎患者外耳道真菌感染及其危险因素分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Jan;39(1):57-60. doi: 10.13201/j.issn.2096-7993.2025.01.012.
3
Study on the microbial diversity of ear canal secretions from patients with otomycosis.

本文引用的文献

1
UK standards for microbiology investigations of ear infection (SMI B1) are inadequate for the recovery of fungal pathogens and laboratory diagnosis of otomycosis: A real-life prospective evaluation.英国耳部感染微生物学检查标准(SMI B1)在真菌性病原体的回收和耳真菌病的实验室诊断方面不够充分:一项真实世界的前瞻性评估。
Mycoses. 2022 Apr;65(4):490-495. doi: 10.1111/myc.13423. Epub 2022 Jan 31.
2
Black aspergilli as causes of otomycosis in the era of molecular diagnostics, a mini-review.黑曲霉作为分子诊断时代真菌性外耳道炎的病因:一篇小型综述。
J Mycol Med. 2022 May;32(2):101240. doi: 10.1016/j.mycmed.2021.101240. Epub 2021 Dec 28.
3
外耳道真菌病患者耳道分泌物微生物多样性研究
Front Surg. 2024 Feb 9;11:1277799. doi: 10.3389/fsurg.2024.1277799. eCollection 2024.
4
Etiology, Predisposing Factors, Clinical Features and Diagnostic Procedure of Otomycosis: A Literature Review.耳真菌病的病因、诱发因素、临床特征及诊断方法:文献综述
J Fungi (Basel). 2023 Jun 13;9(6):662. doi: 10.3390/jof9060662.
5
Relapsing otomycosis despite prolonged systemic antifungal therapy and resolution after topical voriconazole administration: A case report.尽管进行了长期的全身抗真菌治疗,耳真菌病仍复发,局部应用伏立康唑后痊愈:一例报告。
Med Mycol Case Rep. 2022 Dec 28;39:23-25. doi: 10.1016/j.mmcr.2022.12.006. eCollection 2023 Mar.
6
Poly-(lactic--glycolic) Acid Nanoparticles Entrapping Pterostilbene for Targeting Section .聚(乳酸-乙醇酸)纳米粒子包埋白藜芦醇用于靶向给药。
Molecules. 2022 Aug 25;27(17):5424. doi: 10.3390/molecules27175424.
Recurrent Vulvovaginal Candidosis and Cluster Analysis of Clinical Signs and Symptoms: A Laboratory-Based Investigation.
复发性外阴阴道念珠菌病及临床症状体征的聚类分析:一项基于实验室的调查
J Fungi (Basel). 2020 Jul 22;6(3):113. doi: 10.3390/jof6030113.
4
Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia.东南塞尔维亚地区的耳真菌病的物种分布模式和流行病学特征。
J Mycol Med. 2020 Sep;30(3):101011. doi: 10.1016/j.mycmed.2020.101011. Epub 2020 Jun 30.
5
Evaluation of a New Culture Protocol for Enhancing Fungal Detection Rates in Respiratory Samples of Cystic Fibrosis Patients.一种用于提高囊性纤维化患者呼吸道样本真菌检测率的新文化培养方案的评估
J Fungi (Basel). 2020 Jun 9;6(2):82. doi: 10.3390/jof6020082.
6
Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience.耳真菌病中真菌病原体的鉴定及其药敏情况:我们的经验
Int Arch Otorhinolaryngol. 2018 Oct;22(4):400-403. doi: 10.1055/s-0038-1626702. Epub 2018 Apr 12.
7
[Otomycosis: the modern view of etiology and management].[耳霉菌病:病因与治疗的现代观点]
Vestn Otorinolaringol. 2018;83(1):48-51. doi: 10.17116/otorino201883148-51.
8
Otomycosis in immunocompetent patients: Clinical and mycological features. Our experience with 40 cases.免疫功能正常患者的外耳道真菌病:临床和真菌学特征。我们对40例病例的经验。
Clin Otolaryngol. 2018 Feb;43(1):373-377. doi: 10.1111/coa.12966. Epub 2017 Sep 18.
9
Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment.使用碘伏和克霉唑局部治疗耳霉菌病的治愈率比较。
Braz J Otorhinolaryngol. 2018 Jul-Aug;84(4):404-409. doi: 10.1016/j.bjorl.2017.04.004. Epub 2017 May 6.
10
Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid.与黄芩素和鼠李糖脂不同,壳聚糖可抑制烟曲霉DBM 4057生物膜的形成。
World J Microbiol Biotechnol. 2016 Nov;32(11):187. doi: 10.1007/s11274-016-2146-9. Epub 2016 Sep 22.